1. Home
  2. RAPT vs SRBK Comparison

RAPT vs SRBK Comparison

Compare RAPT & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • SRBK
  • Stock Information
  • Founded
  • RAPT 2015
  • SRBK 1887
  • Country
  • RAPT United States
  • SRBK United States
  • Employees
  • RAPT N/A
  • SRBK N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • RAPT Health Care
  • SRBK
  • Exchange
  • RAPT Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • RAPT 117.5M
  • SRBK 109.9M
  • IPO Year
  • RAPT 2019
  • SRBK N/A
  • Fundamental
  • Price
  • RAPT $0.75
  • SRBK $13.05
  • Analyst Decision
  • RAPT Hold
  • SRBK
  • Analyst Count
  • RAPT 7
  • SRBK 0
  • Target Price
  • RAPT $5.00
  • SRBK N/A
  • AVG Volume (30 Days)
  • RAPT 829.4K
  • SRBK 52.1K
  • Earning Date
  • RAPT 05-08-2025
  • SRBK 04-30-2025
  • Dividend Yield
  • RAPT N/A
  • SRBK 0.38%
  • EPS Growth
  • RAPT N/A
  • SRBK N/A
  • EPS
  • RAPT N/A
  • SRBK N/A
  • Revenue
  • RAPT N/A
  • SRBK $27,988,000.00
  • Revenue This Year
  • RAPT N/A
  • SRBK N/A
  • Revenue Next Year
  • RAPT N/A
  • SRBK N/A
  • P/E Ratio
  • RAPT N/A
  • SRBK N/A
  • Revenue Growth
  • RAPT N/A
  • SRBK 23.80
  • 52 Week Low
  • RAPT $0.75
  • SRBK $8.94
  • 52 Week High
  • RAPT $8.58
  • SRBK $13.65
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 33.73
  • SRBK 61.64
  • Support Level
  • RAPT $0.75
  • SRBK $12.94
  • Resistance Level
  • RAPT $0.85
  • SRBK $13.18
  • Average True Range (ATR)
  • RAPT 0.08
  • SRBK 0.22
  • MACD
  • RAPT -0.00
  • SRBK -0.02
  • Stochastic Oscillator
  • RAPT 0.97
  • SRBK 29.82

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: